March 7, 2016, Montréal, Canada – Vantage BioTrials, in conjunction with the Clinical Research Association of Canada (CRAC), has become the first Contract Research Organization (CRO) to proudly organize a unique global conference being held on May 25-26, 2016 in Montréal. With only two months left before the conference, “Canada Talks Pharma 2016: A New Way Forward in Clinical Trials” is the first event of its kind showcasing new innovations and ideas on how to conduct the clinical trials of the future.
“Canada has always been a well-established leader within the drug development sector, however, we often lack conferences such as the one we’re currently organizing where we bring together amazing thought leaders and experts across two full days of educational and informative sessions. As clinical research professionals ourselves, we understand the numerous complexities of conducting research.” explains Viken Bartekian, Co-Founder & Vice-President of Business Development. Vatché Bartekian, President & Founder, continued to state, “Canada continues to be recognized as a world leader in the conduct of clinical trials. We have excellent sites, dedicated investigators, passionate professionals and quality service providers to conduct your trials from beginning to end.”
“We are also very proud to invite several patients and advocacy groups to make their voices heard to a broad industry audience and let us know how they envision closer collaborations between pharma, health care providers and patients in the design and conduct of clinical studies”, adds Vatché Bartekian.
Canada Talks Pharma will be held at the Westin in the historic Old Port of Montréal, Canada on May 25 & 26, 2016. It will focus on providing meaningful solutions through an expert panel of over 30 speakers. They will discuss new approaches for conducting effective, efficient and quality clinical trials. Over twenty-six topics will be presented throughout both days so that delegates will gain the full benefits of attending.
For more information about the conference please visit: www.canadatalkspharma.com
About Vantage BioTrials Inc.
Vantage BioTrials Inc. is a leading Canadian CRO with a unique “a la carte” business model that provides Phase I-IV clinical trial management services to pharmaceutical, biotechnology, generic pharma and medical device companies within North America and Europe.
We are experts in implementing Risk-Based Management through the use of Quality by Design (QbD) methodologies and a lean, efficient project management structure, which helps accelerate the conduct of a study and reduces overall risk. As a result this ensures that your trial is performed correctly, the first time!
For more information about Vantage BioTrials’ services and capabilities, please visit vantagebiotrials.com.